The menopause and its treatment in perspective

Postgraduate Medical Journal

Volumn 77, Issue 907, 2001, Pages 292-304

  Al Azzawi, F ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CALCITONIN; CORTICOSTEROID; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; FLUORIDE; GESTAGEN; HEPARIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NANDROLONE DERIVATIVE; NORETHISTERONE; NORGESTREL; PIPERAZINE ESTRONE SULFATE; PROGESTERONE; RALOXIFENE; TIBOLONE; VITAMIN D;

BONE MASS; BONE METABOLISM; BREAST CANCER; CARDIOVASCULAR SYSTEM; DRUG EFFECT; DRUG RESPONSE; ENDOMETRIUM CANCER; ESTROGEN DEFICIENCY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; MENOPAUSE; PATHOPHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; SYMPTOMATOLOGY;

ADULT; AGED; BONE AND BONES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; HYPERTENSION; MENOPAUSE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS; VASOMOTOR SYSTEM;

EID: 0035022551     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.77.907.292     Document Type: Review

References (92)

1. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age
2. Accelerated disappearance of ovarian follicles in mid-life: Implications for forecasting menopause
3. A model conforming the decline in follicle numbers to the age of menopause in women
4. The distribution of oestrogen receptors in the body
5. Symptoms related to the menopause and sex steroid treatments
6. Effect of oestradiol on turnover of type A monoamine oxidase in the brain
7. Effects of ovarian hormones on norepinephrine and dopamine turnover in individual hypothalamic and extra-hypothalamic nuclei
8. Estrogen replacement therapy and risk of Alzheimer disease
9. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
10. A randomized, doubleblind, placebo-controlled study on the effect of conjugated estrogens on skin thickness
11. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta 1 levels
12. Femoral neck bone density and fracture risk
13. Involutional osteoporosis
14. Bone density in adolescents
15. Osteoporosis: Pathogenesis, diagnosis, prevention and management
16. A prospective study of change in bone mass with age in postmenopausal women
17. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
18. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site
19. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta
20. Cytokines and estrogen in bone: Antiosteoporotic effects
21. Calcitonin secretion in postmenopausal osteoporosis
22. Modulation of intestinal vitamin D receptor by ovariectomy, estrogen and growth hormone
23. Ultrasonographic heel measurements to predict hip fracture in elderly women: The EPIDOS prospective study
24. Quantitative ultrasound techniques for the assessment of osteoporosis: Expert agreement on current status
25. Menopause and the risk of coronary heart disease in women
26. Estrogen replacement therapy and coronary heart disease: A qualitative assessment of the epidemiological evidence
27. Hormone therapy to prevent disease and prolong life in postmenopausal women
28. Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women
29. Menopause-related changes in left ventricular function in healthy women
30. Menopause-induced changes in left ventricular wall thickness
31. High blood pressure and 'ischaemic' ECG patterns in climacteric women
32. The influence of menopause on blood pressure
33. The receipt and despatch of chemical messengers by endothelial cells
34. Cardiovascular protection by oestrogen - A calcium antagonist effect?
35. Endothelium independent relaxation of human coronary arteries by 17β oestradiol in vitro
36. Hypertensive contraception agents and oestrogens
37. Blood pressure changes oestrogen in climacteric women
38. Estrogen use of blood pressure in later life
39. Hormone replacement therapy and blood pressure in hypertensive women
40. Oestrogen therapy and the menopausal syndrome
41. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy
42. The effects of hormone replacement therapy in normal postmenopausal women: Measurement of Doppler derived parameters of aortic flow
43. Estrogen acutely increases peripheral blood flow in postmenopausal women
44. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause
45. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease
46. Oestrogen relaxes human epicardial coronary arteries through nonendothelium-dependent mechanisms
47. Sex differences in regional cerebral blood flow
48. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy
49. Carotid plaque regression on oestrogen replacement: A pilot study
50. The proving of the lipid hypothesis
51. Lipoprotein(a). A genetic risk factor for premature coronary heart disease
52. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women
53. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus
54. Changes in plasma lipids and lipoproteins associated with starting or stopping postmenopausal hormone replacement therapy. Atherosclerosis risk in communities study
55. Post-menopausal hormone replacement therapy: Effects of progestogens on serum lipids and lipoproteins. A review
56. A clinical and metabolic study of continuous combined hormone replacement therapy compared to tibolone
57. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
58. Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population
59. Factor VII activation and menopausal status
60. Hormone replacement therapy and haemostatic function
61. Coagulation, fibrinolysis, and hormone replacement therapy
62. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
63. Risk of venous thromboembolism in users of hormone replacement therapy
64. Heart and estrogen/progestin replacement study (HERS): Design, methods, and baseline characteristics
65. Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
66. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis
67. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
68. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women
69. Prognostic assessment of female fecundity
70. The gonadotropin-releasing hormone agonist stimulation test - A sensitive predictor of performance in the flare-up in vitro fertilization cycle
71. Accuracy of ovarian reserve tests
72. Association of exogenous estrogen and endometrial carcinoma
73. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
74. Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial
75. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
76. Reduction of vertebral fracture risk in postmenopausal women with osteoporosistreated with raloxifene: Results from a 3-year randomized clinical trial
77. Endometrial responses to hormone replacement therapy: The bleeding pattern
78. Investigation of the bleeding patterns of postmenopausal women treated with Estrapak-50
79. Abnormal uterine bleeding on hormone replacement: The importance of intrauterine structural abnormalities
80. Prediction of successful outcome following hysteroscopic laser myomectomy in women with heavy and unscheduled bleeding
81. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study
82. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy
83. Estrogen replacement therapy and the risk of breast cancer: Results from the case-control surveillance study
84. Breast cancer risk after estrogen replacement therapy: Results from the Toronto Breast Cancer Study
85. Decreased mortality in users of estrogen replacement therapy
86. Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies
87. 14 years of follow-up from the Edinburgh randomised trial of breastcancer screening
88. Efficacy of screening mammography. A meta-analysis
89. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone
90. The behavior of endometrial hyperplasia. A long-term study of untreated hyperplasia in 170 patients
91. Risk of endometrial cancer following estrogen replacement with and without progestins